MetLife Investment Management’s Rezolve AI RZLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$317K Buy
123,845
+52,115
+73% +$147K ﹤0.01% 1973
2025
Q4
$184K Sell
71,730
-14,947
-17% -$56.4K ﹤0.01% 2314
2025
Q3
$432K Buy
86,677
+28,956
+50% +$114K ﹤0.01% 1876
2025
Q2
$177K Buy
+57,721
New +$114K ﹤0.01% 2254

Other funds holding RZLV

MetLife Investment Management's RZLV Position: Q1 2026 in Review

MetLife Investment Management increased its Rezolve AI (RZLV) stake by 73% in Q1 2026, buying an estimated $147K and bringing the position to 123,845 shares worth $317K. The position accounts for ﹤0.01% of the portfolio, ranked #1973.

MetLife Investment Management first reported a position in RZLV in Q2 2025 and has held it in 4 quarters since. The position peaked at $432K in Q3 2025. 139 funds tracked by Wall St. Rank hold RZLV as of Q1 2026.

  • MetLife Investment Management held 123,845 shares of Rezolve AI worth $317K as of Q1 2026.
  • MetLife Investment Management bought 52,115 Rezolve AI shares in Q1 2026, an estimated $147K.
  • Rezolve AI made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1973 holding.
  • MetLife Investment Management first reported a position in Rezolve AI in Q2 2025 and has held it in 4 quarters since.
  • MetLife Investment Management's Rezolve AI position peaked at $432K in Q3 2025.
  • 139 funds tracked by Wall St. Rank held Rezolve AI as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.